百晓学者学者目录

刘宏民

郑州大学药学院

个人简介

刘宏民,郑州大学药学院学者,研究方向涉及冶金工业、金属学及金属工艺、有机化工、化学。代表性成果包括BRD4小分子抑制剂筛选平台的建立与活性评价、黄嘌呤衍生物作为LSD1/KDM1A抑制剂的设计合成与生物学评价、冬凌草中对映贝壳杉烯型二萜的结构修饰、苯胺酞嗪类及1-苯基-4-取代酞嗪衍生物的合成与抗肿瘤活性研究等。

精选作品

期刊论文

  1. Kecheng Yang, Wentao Yang, Longwei Guo, Xin-Yu Wang, Hongmin Liu, Xiao-Quan Feng, Yuefeng Bi, Xiao-Le Chen, Xu Gao (2026). Co-Folding-Driven Structural Mapping of Reversible LSD1 Inhibitors Reveals Unexplored Chemical Space and Binding Diversity. Journal of Chemical Information and Modeling.DOI
  2. Yalnaz Naseem, Jianshu Dong, Kecheng Yang, Cong Han, Xinli Ma, Jian Li, Syed Azeem, Hongmin Liu (2026). Structure-Guided Discovery of Isoindolinone–Triazolopyrimidine Hybrids as Potential Skp1–Skp2 Inhibitors: Integrated Docking, Molecular Dynamics, and Machine learning modelling. In Silico Research in Biomedicine.DOI
  3. Shuo Yuan, Yi-Ru Bai, Ruifang Li, Jian Song, Tingting Liu, Sai‐Yang Zhang, Hong‐Min Liu, Ying Xu (2026). Silver-Catalyzed Cascade Reactions for the Synthesis of Indopyran Pseudo-Natural Products as Potent Anti-tumor Agents. Organic Letters.DOI
  4. 郑甲信,刘宏民,王艳芝(2025). 药剂学方向本科毕业设计论文的指导方法探索. 《药学教育》.DOI
  5. Kaizhao Hu, Kun Zhang, Rui-Hao Chui, Wenhui Qiu, Pei-Pei Miao, Linlin Zhang, Meng Ding, Qingjin Zhang, Bing Zhao, Xiao-Jing Shi, Hongmin Liu (2025). Molecular hybridization strategy - discovery of 2,3-diarylpyrazine derivatives as potent Skp2 inhibitors with improved anti-tumor activity and enhanced cisplatin sensitivity. European journal of medicinal chemistry.DOI
  6. Xin-Hui Zhang, Huiqin Kang, Bing-Qian Li, Yuhan Xiong, Shuxian Zheng, Di Zhang, Yuan-Fan Liu, Shi-Yu Li, Ying Liu, Hongmin Liu, Ya Gao, Li-Ying Ma (2025). Structural Optimization of 1,3-Diaryl-1,2,4-triazole-Capped Histone Deacetylase 6 Inhibitors to Obtain Novel Antiesophageal Cancer Candidates. Journal of Medicinal Chemistry.DOI
  7. H. M. Akram, Yu-Lin Liu, Jianshu Dong, Xue-Ke Zhao, Li-Dong Wang, Wen Zhao, Hongmin Liu, LiYing Ma, Cong Han (2025). Discovery of W478, a novel SHMT2 inhibitor for the treatment of esophageal carcinoma. Bioorganic chemistry (Print).DOI
  8. Shuqi Lou, Yingying Huang, Xiaohui Wang, Ying-Mei Li, Feifan Li, Leyi Ma, Yu Zhou, Hongmin Liu, Ling Fu, Yuefeng Bi (2025). Hepatoprotective effects of the active extracts from Chrysanthemi Indici Flos via regulating epigenetic networks. Fitoterapia.DOI
  9. Mengzhen Li, Woonghee Kim, Han Jin, Hong Yang, Xiang-Tai Kong, Xi-Ya Song, Hasan Turkez, Yuefeng Bi, Chengxue Pan, Ling Fu, Hongmin Liu, M. Uhlén, Cheng Zhang, Adil Mardinoğlu (2025). Anticancer effects and mechanisms of Pulsatilla chinensis, Bupleurum chinense and Polyporus umbellatus on human lung carcinoma and hepatoma cells. Computational and Structural Biotechnology Journal.DOI
  10. Nigatu Tadesse, Manni He, Juan Li, Hong‐Min Liu (2025). Challenges of folate species analysis in food and biological matrices by liquid chromatography-tandem mass spectrometery. Bioanalysis.DOI
  11. Ya Gao, Haiqian Nie, Hong‐Min Liu, Xinhui Zhang, Liying Ma (2025). Rational Design, Synthesis, and Biological Assessment of Potential Indole‐Capped HDAC6 Inhibitors for Gastric Cancer Suppression. MedComm.DOI
  12. yanzhi wang, Shanshan Sun, Mengqian Liu, Sai Zhang, Jiaxin Zheng, Hong‐Min Liu (2025). Glycyrrhetinic Acid-Biguanide Conjugate-Based Nanoparticles as a Multi-Functional Drug Delivery System: Paclitaxel Encapsulation and Targeted Therapy. Molecular Pharmaceutics.DOI
  13. Xing‐Jie Dai, Leipeng Xue, Ying Liu, Shuwu Wang, Ying Li, Jiayi Yin, Hao-Zhe Long, Huimin Liu, Ning Wang, Guo‐Liang Lu, Yan Li, Hong‐Min Liu, Bo Wang, Yi‐Chao Zheng (2025). Identification of Novel Phenoxazine-Derived LSD1 Inhibitors Suppressing Gastric Cancer Stemness by β-Catenin Transcriptional Regulation. Journal of Medicinal Chemistry.DOI
  14. Han Jiahui, Wang Shihao, Hongjing Chen, Gu Dongling, Zichen Yang, Hao Wang, Fuqiang Yu, Lingling Chi, Yu Ke, Hong‐Min Liu, Zhang Qiurong (2025). Design, Synthesis, and Antitumor Activity Evaluation of Novel 2,4,7-Trisubstituted Quinazoline Derivatives Containing an Aminomethyl Piperidine Moiety. Russian Journal of Bioorganic Chemistry.DOI
  15. 刘宏民(2024). 实用有机光谱解析.
  16. 何昂,康慧琴,高雅,刘宏民(2024). HDAC6联合SHP2通过下调CD36的表达和糖基化修饰促进胃癌进展及其小分子干预研究. 《2024医药前沿—第九届表观遗传药物研发与交叉学科学术大会会议摘要集》.DOI
  17. 康慧琴,张梦芝,何昂,高雅,刘宏民(2024). 新型选择性三氮唑类HDAC6抑制剂的设计、合成及抗食管癌肿瘤活性研究. 《2024医药前沿—第九届表观遗传药物研发与交叉学科学术大会会议摘要集》.DOI
  18. Xin Yang, Xiang Li, Yuelin Zhang, Shengnan Zhang, Miao Zhang, Chong Sun, Li Yang, Hong‐Min Liu, Shuo Yuan (2024). Targeting undruggable protein KRAS for cancer therapy: novel opportunities and challenges. Future Medicinal Chemistry.DOI
  19. Xueming Li, Fenglian Zhang, Yu Ke, Hong‐Min Liu, Zhenbo Hu, Zhenbo Hu, Liuya Wei (2024). Differentiation of Acute Leukemia Cells Including Cells with MLL-AF4 Rearrangements Induced by Jiyuan Oridonin A. Recent Patents on Anti-Cancer Drug Discovery.DOI
  20. Shihao Wang, Zichen Yang, Dongling Gu, Jiahui Han, Hongjing Chen, Hao Wang, Jiaxin Zheng, Hong‐Min Liu, Yu Ke, Qiurong Zhang (2024). Design, synthesis, and evaluation of antitumor activity of quinazoline derivatives containing different terminal segments of basic amine groups. Medicinal Chemistry Research.DOI
  21. Dandan Shen, Yuelin Zhang, Xiang Li, Yi‐Ru Bai, Jun‐Feng Xiong, Dong‐Jie Seng, Yao‐Dong Zhang, Hong‐Min Liu, Shuo Yuan, Li Yang (2024). The mechanism of action and chemical synthesis of FDA newly approved drug molecules. Drug Development Research.DOI
  22. Yi‐Ru Bai, Wei‐Guang Yang, Rui Jia, Ju‐Shan Sun, Dandan Shen, Hong‐Min Liu, Shuo Yuan (2024). The recent advance and prospect of poly(ADP‐ribose) polymerase inhibitors for the treatment of cancer. Medicinal Research Reviews.DOI
  23. Yi‐Ru Bai, Dong‐Jie Seng, Ying Cao Xu, Yaodong Zhang, Wenjuan Zhou, Yang-Yang Jia, Jian Zheng Song, Zhangxu He, Hong‐Min Liu, Shuo Yuan (2024). A comprehensive review of small molecule drugs approved by the FDA in 2023: Advances and prospects. European Journal of Medicinal Chemistry.DOI
  24. Moges Dessale Asmamaw, Ang He, Lirong Zhang, Hong‐Min Liu, Ya Gao (2024). Histone deacetylase complexes: Structure, regulation and function. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.DOI
  25. Juan Li, Wenchao Hu, Mengxue Liu, Yingqi Tian, Manni He, Hong‐Min Liu (2024). Simultaneous determination of folic acid photolysis products and oxidized guanine derivatives in plasma by liquid chromatography‐tandem mass spectrometry. Journal of Separation Science.DOI
  26. Yajie Liu, Yajie Liu, Pengxing He, Xubin Ma, Ying-qi Tian, Yu Zhang, Yang Wang, Yingjie Jia, Hong‐Min Liu, Ying Liu, Ying Liu, Yichao Xu (2024). The combination of SLC7A11 inhibitor and oridonin synergistically inhibits cervical cancer cell growth by decreasing the NADPH/NADP+ ratio. Genes & Diseases.DOI
  27. Ning-Jie Guo, Bo Wang, Yu Zhang, Huiqin Kang, Haiqian Nie, Meng-Kai Feng, Xi-Ya Zhang, Lijuan Zhao, Ning Wang, Hong‐Min Liu, Yi‐Chao Zheng, Wen J. Li, Ya Gao (2024). USP7 as an emerging therapeutic target: A key regulator of protein homeostasis. International Journal of Biological Macromolecules.DOI
  28. Liang Shen, Bo Wang, Shaopeng Wang, Shi‐Kun Ji, Meng‐Jie Fu, Shuwu Wang, Wenqing Hou, Xing‐Jie Dai, Hong‐Min Liu (2024). Combination Therapy and Dual-Target Inhibitors Based on LSD1: New Emerging Tools in Cancer Therapy. Journal of Medicinal Chemistry.DOI
  29. 王妮,郑姿君,贾小苹,赵梦圆,王亚蕾,周臣,王志佳,肖泽霖,刘宏民,可钰(2023). 济源冬凌草甲素衍生物作为潜在抗肿瘤药物的合成及药理学活性研究(英文). 《有机化学》.
  30. Fuqiang Yu, Lingling Chi, Hao Wang, Chao Gao, Honglin Dai, Limin Liu, Zhengjie Wang, Yu Ke, Hong‐Min Liu, Qiurong Zhang (2023). Design, synthesis and antitumor activity evaluation of 5-cyano-2,4,6-substituted pyrimidine derivatives containing acrylamide group. Medicinal Chemistry Research.DOI
  31. Hao Wang, Lingling Chi, Fuqiang Yu, Honglin Dai, Chao Gao, Xiaojie Si, Zhengjie Wang, Limin Liu, Limin Liu, Jiaxin Zheng, Lihong Shan, Hong‐Min Liu, Qiurong Zhang (2023). Annual review of KRAS inhibitors in 2022. European Journal of Medicinal Chemistry.DOI
  32. Yun Fei Xu, Ziting Wang, Lei Zhang, Congying Gao, Fahui Li, Xueming Li, Yu Ke, Hong‐Min Liu, Zhenbo Hu, Liuya Wei, Zhe‐Sheng Chen (2023). Differentiation of imatinib -resistant chronic myeloid leukemia cells with BCR-ABL-T315I mutation induced by Jiyuan Oridonin A. Journal of Cancer.DOI
  33. 高潮,司晓杰,池玲玲,王浩,戴洪林,刘丽敏,汪正捷,张洋,王涛,周耀传,郑甲信,可钰,刘宏民,张秋荣(2022). 含苯甲醚结构的2,4,5,6-四取代嘧啶衍生物的合成及抗增殖活性研究(英文). 《有机化学》.
  34. 汪正捷,戴洪林,司晓杰,高潮,刘丽敏,张路野,张洋,宋亚丹,赵培荣,郑甲信,可钰,刘宏民,张秋荣(2022). 含三氟甲基的2,4,6-三取代喹唑啉衍生物的合成及抗肿瘤活性研究. 《有机化学》.
  35. 李娟,徐海伟,单丽红,张秋荣,刘宏民(2022). 大型精密仪器在本科药物化学实验教学改革探索. 《教育教学论坛》.
  36. 戴洪林,司晓杰,池玲玲,王浩,高潮,汪正捷,刘丽敏,马家婕,于富强,刘宏民,可钰,张秋荣(2022). 含噻唑结构的2,4,6-三取代喹唑啉衍生物的合成及抗肿瘤活性研究. 《有机化学》.
  37. 高潮,张玉桐,池玲玲,王浩,马家婕,毕梦鑫,戴洪林,司晓杰,刘丽敏,张洋,郑甲信,可钰,刘宏民,张秋荣(2022). 新型2,4,6-三取代嘧啶衍生物的合成及抗增殖活性评价. 《有机化学》.
  38. Fahui Li, Congying Gao, Xueming Li, Jiangyun Wang, Yao Zhao, Yu Ke, Ying Liu, Hong‐Min Liu, Zhenbo Hu, Liuya Wei, Zhe‐Sheng Chen (2022). Jiyuan oridonin A induces differentiation of acute myeloid leukemia cells including leukemic stem-like cells. Frontiers in Pharmacology.DOI
  39. Xiaojie Si, Chao Gao, Lingling Chi, Hao Wang, Yutong Zhang, Honglin Dai, Limin Liu, Zhangjie Wang, Jiaxin Zheng, Yu Ke, Hong‐Min Liu, Qiurong Zhang (2022). Synthesis and in vitro antitumor activity evaluation of novel 5-cyano-6-phenyl-2,4-disubstituted-pyrimidine derivatives. Medicinal Chemistry Research.DOI
  40. Chao Gao, Honglin Dai, Xiaojie Si, Yutong Zhang, Limin Liu, Zhengjie Wang, Yaqi Meng, Yang Zhang, Tao Wang, Jiaxin Zheng, Lihong Shan, Hong‐Min Liu, Qiurong Zhang (2022). Synthesis and Antitumor Activity Evaluation of Novel 2-Amino-5-Ethylpyrimidine Derivatives. Russian Journal of Bioorganic Chemistry.DOI
  41. Xiaojie Si, Honglin Dai, Chao Gao, Hao Wang, Lingling Chi, Zhangjie Wang, Limin Liu, Luye Zhang, Erdong Li, Jiaxin Zheng, Yaoyao Wang, Yu Ke, Hong‐Min Liu, Qiurong Zhang (2022). Synthesis and antitumor activity evaluation in vitro of 4-aminoquinazoline derivatives containing 1,3,4-thiadiazole. Medicinal Chemistry Research.DOI
  42. Lihong Shan, Zhaoxiang Li, Huabin Chen, Meng Ge, Yingying Sun, Ying Jie Sun, Yaru Li, Hongyu Li, Ling Fu, Hong‐Min Liu (2022). 6-Heterocyclic carboxylic ester derivatives of gliotoxin lead to LSD1 inhibitors in gastric cancer cells. Bioorganic Chemistry.DOI
  43. 黄利华,郭佳稳,黄明杰,宋文淇,符运栋,游亚珍,刘宏民(2021). 苯环丙胺类LSD1抑制剂设计、合成及活性研究. 《郑州大学学报(理学版)》.DOI
  44. 宋小杰,李苗苗,吕琪妍,崔惠芳,刘宏民(2021). 蓝色超小赖氨酸-京尼平纳米粒制备及肿瘤细胞染色. 《中国现代应用药学》.
  45. 王少敏,张蒙蒙,郭燕子,陈丽花,刘宏民(2021). 液相色谱-质谱法分析地黄生长期中内源性激素的变化. 《郑州大学学报(理学版)》.DOI
  46. 孙默然,白磊阳,向俊鸿,杨华,于德泉,刘宏民(2021). 去对称化策略合成Ingramycin右部片断. 《有机化学》.
  47. 张洋,张路野,王继宽,刘丽敏,王涛,栗娜,汪正捷,刘秀娟,陈雅欣,赵丹琳,郑甲信,单丽红,刘宏民,张秋荣(2021). 新型2,4,6,-取代嘧啶衍生物的设计、合成和抗肿瘤活性研究(英文). 《有机化学》.
  48. 徐晨淏,龚云鹏,陈雅欣,宋启梦,李娇,郑一超,李雯,孙凯,刘宏民(2021). 基于ABBV-075的新型溴结构域蛋白4(BRD4)小分子抑制剂的设计、合成及活性评价. 《有机化学》.
  49. 张丹青,柳旭,庞晓静,刘宏民,张秋荣(2021). 新型吲哚-嘧啶联芳类化合物的设计、合成及抗肿瘤活性研究(英文). 《有机化学》.
  50. Limin Liu, Zhengjie Wang, Chao Gao, Honglin Dai, Xiaojie Si, Yang Zhang, Yaqi Meng, Jiaxin Zheng, Yu Ke, Hong‐Min Liu, Qiurong Zhang (2021). Design, synthesis and antitumor activity evaluation of trifluoromethyl-substituted pyrimidine derivatives. Bioorganic & Medicinal Chemistry Letters.DOI
  51. Meihua Qu, Yu Duan, Min Zhao, Zhanju Wang, Mengjie Zhao, Yao Zhao, Haihua Wang, Yu Ke, Ying Liu, Hong‐Min Liu, Liuya Wei, Zhenbo Hu (2021). Jiyuan Oridonin A Overcomes Differentiation Blockade in Acute Myeloid Leukemia Cells With MLL Rearrangements via Multiple Signaling Pathways. Frontiers in Oncology.DOI
  52. Danqing Zhang, Xu Liu, Xiaojing Pang, Hong‐Min Liu, Qiurong Zhang (2021). Design, Synthesis and Anticancer Activity Studies of Novel Indole-Pyrimidine Biaryl Derivatives. Chinese Journal of Organic Chemistry.DOI
  53. 唐凯,左佳辉,余斌,刘宏民(2020). 组蛋白去甲基化酶5的结构、功能及其抑制剂研究进展. 《药学进展》.
  54. 张路野,张洋,包崇男,杨鹏,李二冬,孟娅琪,崔飞,周蕊,黄诗雨,郑甲信,单丽红,刘宏民,张秋荣(2020). 新型1,3-二取代酞嗪酮类衍生物的合成及抗肿瘤活性研究. 《有机化学》.
  55. 张路野,张洋,汪正捷,王涛,李二冬,刘丽敏,刘秀娟,郑甲信,可钰,单丽红,刘宏民,张秋荣(2020). 含丙烯酰胺结构的喹唑啉衍生物的合成及抗肿瘤活性研究(英文). 《有机化学》.
  56. 李二冬,孟娅琪,张路野,张洋,周蕊,刘丽敏,栗娜,辛景超,郑甲信,单丽红,刘宏民,张秋荣(2020). 含苯并噻唑砌块的2,4,6-三取代嘧啶衍生物的合成及抗肿瘤活性评价(英文). 《有机化学》.
  57. 张洋,张路野,刘丽敏,王涛,孟娅琪,栗娜,李二冬,汪正捷,刘秀娟,郑甲信,单丽红,刘宏民,张秋荣(2020). 新型腙基取代嘧啶衍生物的合成及抗肿瘤活性评价(英文). 《有机化学》.
  58. 张路野,张洋,汪正捷,王涛,刘丽敏,刘秀娟,李二冬,宋攀攀,郑甲信,可钰,单丽红,刘宏民,张秋荣(2020). 含苯并噻唑的4-氨基喹唑啉衍生物的合成及抗肿瘤活性研究(英文). 《有机化学》.
  59. Hang Xie, Jian-Jia Liang, Yalei Wang, Tianxing Hu, Jinyi Wang, Ruihua Yang, Jun-Ke Yan, Qiurong Zhang, Xia Xu, Hong‐Min Liu, Yu Ke (2020). The design, synthesis and anti-tumor mechanism study of new androgen receptor degrader. European Journal of Medicinal Chemistry.DOI
  60. Yang Zhang, Luye Zhang, Limin Liu, Tao Wang, Yaqi Meng, Na Li, Erdong Li, Zhengjie Wang, Xiujuan Liu, Jiaxin Zheng, Lihong Shan, Hong‐Min Liu, Qiurong Zhang (2020). Synthesis and Antitumor Activity Evaluation of Novel Hydrazone-Substituted Pyrimidine Derivatives. Chinese Journal of Organic Chemistry.DOI
  61. 王少敏,牛颖,代敏,魏一,刘宏民(2019). 顶空-气相色谱-质谱法同时测定7种甲磺酸酯类杂质. 《郑州大学学报(理学版)》.DOI
  62. 孟娅琪,李二冬,张洋,刘栓,包崇男,杨鹏,张路野,张丹青,王继宽,陈雅欣,栗娜,辛景超,赵培荣,可钰,张秋荣,刘宏民(2019). 含三氟甲基的2,4-取代嘧啶衍生物的合成及抗肿瘤活性评价(英文). 《有机化学》.
  63. 李二冬,孟娅琪,张路野,张洋,王继宽,张丹青,宋攀攀,辛景超,栗娜,郑甲信,可钰,刘宏民,张秋荣(2019). 含脲砌块的4-氨基喹唑啉衍生物的设计、合成及抗肿瘤活性研究(英文). 《有机化学》.
  64. Zhiru Wang, Wen-Ting Kang, Yinghua You, Jing‐Ru Pang, Hongmei Ren, Zhenhe Suo, Hong‐Min Liu, Yi‐Chao Zheng (2019). USP7: Novel Drug Target in Cancer Therapy. Frontiers in Pharmacology.DOI
  65. Juan Li, Qingli Wang, Yi‐Chao Zheng, Piao Zhou, Xia Xu, Xueqi Liu, Longfei Zhao, Hong‐Min Liu (2019). Development of a mass spectrometry-based pseudotargeted metabolomics strategy to analyze hormone-stimulated gastric cancer cells. Journal of Pharmaceutical and Biomedical Analysis.DOI
  66. Jianwei Zhao, Zeng-Hui Wu, Jia–Wen Guo, Ming-Jie Huang, Ya-Zhen You, Hong‐Min Liu, Li‐Hua Huang (2019). Synthesis and anti-gastric cancer activity evaluation of novel triazole nucleobase analogues containing steroidal/coumarin/quinoline moieties. European Journal of Medicinal Chemistry.DOI
  67. Jianwei Zhao, Jia–Wen Guo, Ming-Jie Huang, Ya-Zhen You, Zeng-Hui Wu, Hong‐Min Liu, Li‐Hua Huang (2019). Design, synthesis and biological evaluation of new steroidal β-triazoly enones as potent antiproliferative agents. Steroids.DOI
  68. Er-dong Li, Lin Qiao, Yaqi Meng, Lu-ye Zhang, Panpan Song, Na Li, Jingchao Xin, Peng Yang, Chongnan Bao, Dan-qing Zhang, Yang Zhang, Ji-kuan Wang, Qiurong Zhang, Hong‐Min Liu (2019). 2,4-Disubstituted quinazolines targeting breast cancer cells via EGFR-PI3K. European Journal of Medicinal Chemistry.DOI
  69. 可钰,吴春丽,张秋荣,刘宏民(2018). 对药学专业研究生波谱学解析课程建设的几点思考. 《决策探索(下)》.
  70. 栗娜,辛景超,孟娅琪,李二冬,马启胜,包崇男,杨鹏,宋攀攀,崔飞,赵培荣,李雯,可钰,张秋荣,刘宏民(2018). 含苯并咪唑的2,4-取代喹唑啉衍生物的合成及抗肿瘤活性评价(英文). 《有机化学》.
  71. 栗娜,辛景超,马启胜,李二冬,孟娅琪,包崇男,杨鹏,宋攀攀,崔飞,陈鹏举,顾一飞,赵培荣,可钰,刘宏民,张秋荣(2018). 1,2,3-三氮唑[4,5-d]嘧啶衍生物的合成及抗肿瘤活性评价. 《有机化学》.
  72. 孙默然,代磊,杨华,刘宏民,于德泉(2018). Hydramicromelins A,B和C母核的对映选择性合成. 《有机化学》.
  73. 孟祥川,栗娜,李二冬,常通航,刘梦,柳晴怡,袁文娟,张晴晴,张钰,周智玉,宋攀攀,刘宏民,张秋荣(2018). 2-甲硫基-4-芳胺喹唑啉衍生物的合成及抗肿瘤活性评价. 《有机化学》.
  74. 袁硕,王四喜,陈锦杰,赵龙飞,余斌,刘宏民(2018). 苯胺促进的异苯并呋喃酮类衍生物的合成. 《有机化学》.
  75. 辛景超,栗娜,马启胜,李二冬,孟祥川,可钰,刘宏民,张秋荣(2018). 1-苯基-4-取代酞嗪衍生物合成及抗肿瘤活性评价(英文). 《有机化学》.
  76. Juan Li, Qingli Wang, Piao Zhou, Qiqi Fan, Tianze Cao, Yatong Li, Mengxuan Li, Zhang Yue, Mengfei Bian, Hongmin Liu (2018). Development of LC-MS-based pseudotargeted metabolomics method and its application in hormone-stimulated MGC803 Cells. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  77. Yunkai Shi, Wenjuan Zhou, Yu Liu, Jingjing Song, Yanyan Que, Wen Zhao, Bin Yu, Hongmin Liu (2018). Discovery of a potent inhibitor of DCN1-UBC12 interaction. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  78. Piao Zhou, Qiqi Fan, Juan Li, Mengchen An, Hongmin Liu (2018). Establishment and application of 23 kinds of nucleosides and modified nucleosides in cell samples. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  79. Na Li, Jingchao Xin, Yaqi Meng, Erdong Li, Chongnan Bao, Peng Yang, Jiaxin Zheng, Qiurong Zhang, Hongmin Liu (2018). Design and synthesis of novel 2,4,6-substituted pyrimidine derivatives as potential antitumor agents. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  80. Zhangxu He, Chen Liu, Yi Ying Wang, Liying Ma, Hongmin Liu (2018). Design,synthesis,and structure-activity relationship of novel pan HDAC inhibitors based on indole. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  81. Jingchao Xin, Na Li, Erdong Li, Yaqi,Meng, Jiaxin,Zheng, Qiurong Zhang, Hongmin Liu (2018). The design,synthesis and antitumor activity of novel tetrazolo[5,1-a]phthalazine derivatives. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  82. Qianqian Liang, Hao Zhang, Liyan Zhou, Bing Zhao, Hongmin Liu (2018). Design synthesis and bioactivity evaluation of quinoline KDM5B inhibitors. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  83. Qisheng Ma, Yinghua You, Xingyu Ma, Qian li, Tongtong Li, Zhiyang Ruan, Zhiling Chen, Yichao Zheng, Bin Yu, Hongmin Liu (2018). Design,synthesis and biological evaluation of indolines as potent lysine specific demethylase 1(LSD1/KDM1A) inhibitors. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  84. Yaqi Meng, Erdong Li, Na Li, Jingchao Xin, Chongnan Bao, Peng Yang, Jiaxin Zheng, Qiurong Zhang, Hongmin Liu (2018). USP7:a promising target for cancer therapy. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  85. Feifei Yang, Liying Ma, Hongmin Liu (2018). Design,synthesis and biological evaluation of novel indole-based hybrids. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  86. Shuai Wang, Lijie Zhao, Kai Tang, Xiaojing Shi, Lina Ding, Yichao Zheng, Bin Yu, Hongmin Liu (2018). The development of small molecules targeting DCN1-UBC12 protein-protein interactions. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  87. Li Zhu, Xue An, Peipei Gao, Lihong Shan, Hongmin Liu (2018). Design and synthesis of 15β,16β-methylene steroid-2-benzylidene-4,6-diene-3,17-dione derivatives. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  88. Maksim Semenov, Yuan Shuo, Lingyu Li, Bin Yu, Hongmin Liu, Wen Zhao (2018). Structure-based discovery and optimization of new potent and selective BET inhibitors for potential treatment of heart failure. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  89. Yanan Li, YuANDi Zhao, Peng Yang, Linlin Lou, Yiying Wang, Chen Liu, Qingyuan Wei, Hongmin Liu (2018). Design and synthesis of novel 6-chloro-purine-based derivatives as potential selective anti-lung cancer agents. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  90. Jianjia Liang, Hang Xie, Ruihua Yang, Longfei Zhao, Ying Liu, Yu Ke, Hongmin Liu (2018). A "Click Chemistry Platform" for the rapid synthesis of small-molecule-mediated degradation of the androgen receptor. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  91. Yuandi Zhao, Bo Wang, Yanan Li, Liying Ma, Hongmin Liu (2018). Design,synthesis of novel 1,2,3-triazoles and derivatives as potential IDO1 inhibitors. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  92. Yandan Ren, Mengying Zhang, Yang Wang, Tianli Fan, Qi Zhao, Yu Zhao, Hongmin Liu, Guiqin Hou, Zhaoming Lu (2018). FLI-06 suppresses proliferation,induces apoptosis and cell cycle arrest by targeting LSD1 and Notch pathway in esophageal squamous cell carcinoma cells. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  93. Xiaojing Shi, Xiaojing Li, Yi Huang, Jun Dong, Hongmin Liu (2018). Characterize the expression of Skp2 in gastric carcinoma:promotion of tumorigenesis. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  94. Ying Liu, Longfei Zhao, Jianjia Liang, Zhusong Cao, Xiaojing Li, Le Yang, Bo Wang, Fengzhi Suo, Jinyi Wang, Ruihua Yang, Yu Ke, Liying Ma, Hongmin Liu (2018). Design,synthesis and in vitro activity of novel triazine-based LSD1 inhibitors. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  95. Zhongrui Li, Fengzhi Suo, DANDan Shen, Shuo Yuan, Bin Yu, Yichao Zheng, Hongmin Liu (2018). Identification of natural protoberberine alkaloids as potent,selective,and cellular active LSD1/KDM1A inhibitors for AML treatment. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  96. Dandan Shen, Shuai Wang, Qimeng Song, Yichao Zheng, Hongmin Liu (2018). Establishment of screening platform for small molecular inhibitors of BRD4 and screening and activity evaluation of inhibitors. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  97. Lijuan Zhao, Ting Zhang, Dandan Shen, Yingying Li, Yichao Zheng, Hongmin Liu (2018). Exosomal LSD1 mediates sternness in gastric cancer. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  98. Yichao Zheng, Hongmin Liu (2018). Interruption of a paracrine amplification loop between LSD1 and TGF β1 by LSD1 inhibitor. 《第11届世界华人药物化学研讨会(ISCMC 2018)》.
  99. Ting Ma, Wenjun Peng, Lisha Zhao, Ruyue Wang, Qian Wang, Yanqin Tu, Hongmin Liu (2018). Polyphyllin G induced apoptosis and protective autophagy by targeting MAPK pathway in colorectal carcinoma cells. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  100. Wenjuan Zhou, Liying Ma, Lina Ding, Hui Qiao, Jing Yang, Lingyu Li, Qian Guo, Hongmin Liu, Zhenhe Suo, Zhao Wen (2018). Exploration of 5-cyano-6-phenyl-pyrimidin-based derivatives as potent inhibitors against DCN1-UBE2M interaction. 《第11届世界华人药物化学研讨会(ISCMC 2018)》.
  101. Tiantian Qin, Dongxiao Yang, Xueyan Zhang, Leilei Li, Weihua Liu, Junfeng Huo, Xiaoli Shi, Cong Wang, Hongmin Liu (2018). ASC26,a Selective ABCB1 inhibitor reverses ABCB1-mediated drug resistance in cancer cells. 《第11届世界华人药物化学研讨会(ISCMC 2018)》.
  102. Zhenya Wang, Xiaoning Hu, Xiaodong Mou, Congcong Wang, Yuanyuan Li, Xinli Chen, Yayun Tan, Chunli Wu, Hongmin Liu, Haiwei Xu (2018). Design,synthesis and anti-virus activity of a novel butenolide as inhibitors of neuraminidase from influenza A virus H1N1 in vitro and in Vivo. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  103. Yaquan Cao, Bing Zhao, Lingling Ren, Qinyan Shi, Yunan Su, Hongmin Liu (2018). Histone demethylase KDM5B. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  104. Shuo Yuan, Si-Xi Wang, Tongtong Li, Jie Zhang, Qiangyan Zhang, Wen Zhao, Bin Yu, Hongmin Liu (2018). Design and synthesis of potent and selective BRD4 inhibitors. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  105. Shuo Yuan, Dandan Shen, Jinjie Chen, Zixin Qiu, Yonggang Liu, Yichao Zheng, Bin Yu, Hongmin Liu (2018). Brφnsted acid-catalyzed direct C(sp2)-H activation enabling the discovery of biaryl compounds as novel BRD4 inhibitors. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  106. Kai Tang, Bin Yu, Hongmin Liu (2018). Discovery of new tetrahydroisoquinoline-based LSD1/KDM1A inhibitors from natural product Higenamine. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  107. Peng Yang, Yanan Li, Yuanzi Zhao, Qiurong Zhang, Linlin Lou, Qingyuan Wei, Chen Liu, Yiying Wang, Hongmin Liu (2018). Design,synthesis and biological evaluation of imidazo[4,5-c]pyridine derivatives as potential antitumor agents. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  108. Qiuhua Zhang, Bin Yu, Hongmin Liu (2018). Structure-based design of KDM5A/B protein degraders. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  109. Erdong Li, Yaqi Meng, Jingchao Xin, Na Li, Chongnan Bao, Peng Yang, Peirong Zhao, Qiurong Zhang, Hongmin Liu (2018). Design and synthesis of novel 2,4,5-trisubstituted quinazoline derivatives. 《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》.
  110. Qisheng Ma, Yongfang Yao, Yi‐Chao Zheng, Siqi Feng, Junbiao Chang, Bin Yu, Hong‐Min Liu (2018). Ligand-based design, synthesis and biological evaluation of xanthine derivatives as LSD1/KDM1A inhibitors. European Journal of Medicinal Chemistry.DOI
  111. Yu Ke, Jian-Jia Liang, Rui-Juan Hou, Mingming Li, Longfei Zhao, Wancong Wang, Ying Liu, Hang Xie, Ruihua Yang, Tianxing Hu, Jinyi Wang, Hong‐Min Liu (2018). Synthesis and biological evaluation of novel Jiyuan Oridonin A-1,2,3-triazole-azole derivatives as antiproliferative agents. European Journal of Medicinal Chemistry.DOI
  112. Yong‐Gang Hua, Qian‐Qian Yang, Yi Yang, Mei‐Jing Wang, Wen-Chao Chu, Peng-Yan Bai, De-Yun Cui, En Zhang, Hong‐Min Liu (2018). Metal-free synthesis of 1,2-amino alcohols by one-pot olefin aziridination and acid ring-opening. Tetrahedron Letters.DOI
  113. Yong‐Gang Hua, Lan‐Ping Han, Qian‐Qian Yang, Mei‐Jing Wang, En Zhang, Hong‐Min Liu (2018). A Practical and Efficient Stereoselective Synthesis of (S)‐Rivastigmine and (R)‐Rivastigmine. ChemistrySelect.DOI
  114. Yunkai Shi, Bo Wang, Xiaoli Shi, Yuandi Zhao, Bin Yu, Hong‐Min Liu (2018). Synthesis and biological evaluation of new steroidal pyridines as potential anti-prostate cancer agents. European Journal of Medicinal Chemistry.DOI
  115. 凡丞,鲁照明,张幸丽,田菲,白一汝,赵琦,彭柯峥,刘宏民,侯桂琴(2017). 食管鳞癌Eca109细胞中PI3K/AKT/mTOR信号通路对LSD1的调控作用. 《郑州大学学报(医学版)》.
  116. 李娟,粟颍倩,王清利,周甜,周飘,可钰,刘宏民(2017). 紫杉醇与JD27联合用药在大鼠体内的药代动力学研究. 《第三届全国药物代谢动力学青年科学家论坛暨刘昌孝人才奖颁奖大会会议资料集》.DOI
  117. 张恩,崔得运,孙伟,李鹏云,徐锦梅,刘宏民(2017). 呋喃阿洛糖衍生物水解产物的结构确定. 《波谱学杂志》.
  118. 方莉,王赛琪,陈雪梅,薛博涵,王冠涛,李玉萍,刘宏民(2017). 冬凌草活性成分KY3对食管癌EC109细胞增殖的抑制作用. 《郑州大学学报(医学版)》.
  119. 余斌,蔡祖恽,王帅,刘宏民(2017). 核外氮杂甾体的合成及其抗肿瘤活性研究进展. 《有机化学》.
  120. 张恩,王铭铭,徐帅民,王上,赵娣,白鹏燕,崔得运,化永刚,王亚娜,秦上尚,刘宏民(2017). 吡啶查尔酮衍生物的合成及抑制耐甲氧西林金黄色葡萄球菌活性评价. 《有机化学》.
  121. 张恩,王上,焦伟伟,王铭铭,岳静飞,徐帅民,王亚娜,Horst-Dieter Ambrosi,刘宏民(2017). 3-epi-Jaspine B类似物的合成和抗肿瘤活性评价. 《有机化学》.
  122. 宋攀攀,栗娜,崔飞,辛景超,张孝松,曹钦坡,王超杰,戴文杰,孟祥川,刘梦,常通航,柳晴怡,孙月红,可钰,张秋荣,刘宏民(2017). 2,4,6-三取代嘧啶衍生物的合成及体外抗肿瘤活性研究. 《有机化学》.
  123. Wen Li, Lina Ding, Hong‐Min Liu, Qidong You (2017). Synthesis, biological evaluation, and molecular docking of ropivacaine analogs as local anesthetic agents. Medicinal Chemistry Research.DOI
  124. Peng-Fei Geng, Congcong Wang, Zhonghua Li, Xiaoning Hu, Taoqian Zhao, Dong‐Jun Fu, Bing Qiang Zhao, Bin Yu, Hong‐Min Liu (2017). Design, synthesis and preliminary biological evaluation of 5,8-dihydropteridine-6,7-diones that induce apoptosis and suppress cell migration. European Journal of Medicinal Chemistry.DOI
  125. Zhonghua Li, Taoqian Zhao, Xue‐qi Liu, Bing Qiang Zhao, Chao Wang, Peng Geng, Yaquan Cao, Dong‐Jun Fu, Liping Jiang, Bin Yu, Hong‐Min Liu (2017). Synthesis and preliminary antiproliferative activity of new pteridin-7(8H)-one derivatives. European Journal of Medicinal Chemistry.DOI
  126. Zhonghua Li, Xue‐Qi Liu, Taoqian Zhao, Peng Geng, Wen-Ge Guo, Bin Yu, Hong‐Min Liu (2017). Design, synthesis and preliminary biological evaluation of new [1,2,3]triazolo[4,5- d ]pyrimidine/thiourea hybrids as antiproliferative agents. European Journal of Medicinal Chemistry.DOI
  127. Zhonghua Li, Xue‐Qi Liu, Taoqian Zhao, Peng-Fei Geng, Ying Liu, Bing Qiang Zhao, Wen-Ge Guo, Bin Yu, Hong‐Min Liu (2017). Design, synthesis and preliminary antiproliferative activity studies of new diheteroaryl thioether derivatives. Bioorganic & Medicinal Chemistry Letters.DOI
  128. Dong‐Jun Fu, Ruo-Han Zhao, Jiahuan Li, Jiajia Yang, Ruo-Wang Mao, Bowen Wu, Ping Li, Xiaolin Zi, Qingqing Zhang, Huijie Cai, Sai‐Yang Zhang, Yanbing Zhang, Hong‐Min Liu (2017). Molecular diversity of phenothiazines: design and synthesis of phenothiazine–dithiocarbamate hybrids as potential cell cycle blockers. Molecular Diversity.DOI
  129. Zhong-Hua Li, Xue‐Qi Liu, Peng Geng, Ji Zhang, Jinlian Ma, Bo Wang, Taoqian Zhao, Bing Qiang Zhao, Xinhui Zhang, Bin Yu, Hong‐Min Liu (2017). Design, synthesis and antiproliferative activity of thiazolo[5,4-d]pyrimidine derivatives through the atom replacement strategy. European Journal of Medicinal Chemistry.DOI
  130. Dong‐Jun Fu, Jian Song, Yuhui Hou, Ruo-Han Zhao, Jiahuan Li, Ruo-Wang Mao, Jiajia Yang, Ping Li, Xiaolin Zi, Zhonghua Li, Qingqing Zhang, Feiyan Wang, Sai‐Yang Zhang, Yanbing Zhang, Hong‐Min Liu (2017). Discovery of 5,6-diaryl-1,2,4-triazines hybrids as potential apoptosis inducers. European Journal of Medicinal Chemistry.DOI
  131. Panpan Song, Fei Cui, Na Li, Jingchao Xin, Qisheng Ma, Xiangchuan Meng, Chaojie Wang, Qinpo Cao, Yifei Gu, Yu Ke, Qiurong Zhang, Hong‐Min Liu (2017). Synthesis, Cytotoxic Activity Evaluation of Novel 1,2,3‐Triazole Linked Quinazoline Derivatives. Chinese Journal of Chemistry.DOI
  132. Feng‐Wu Liu, Wenke Xu, Hui Yang, Yingju Liu, Yingchun Hua, Bin He, Xin Ning, Zhiyan Qin, Hong‐Min Liu (2017). Facile Approaches to 2-Deoxy-d-glucose and 2-Deoxy-α-d-glucopyranonucleosides from d-Glucal. Synthesis.DOI
  133. Kezheng Peng, Yu Ke, Qi Zhao, Fei Tian, Hong‐Min Liu, Guiqin Hou, Zhaoming Lu (2017). OP16, a novel ent-kaurene diterpenoid, potentiates the antitumor effect of rapamycin by inhibiting rapamycin-induced feedback activation of Akt signaling in esophageal squamous cell carcinoma. Biochemical Pharmacology.DOI
  134. Cong Wang, Liubin Guo, Saiqi Wang, Junwei Wang, Yongmei Li, Yinhui Dou, Ran Wang, Hongge Shi, Yu Ke, Hong‐Min Liu (2017). Anti-proliferative effect of Jesridonin on paclitaxel-resistant EC109 human esophageal carcinoma cells. International Journal of Molecular Medicine.DOI
  135. Biao Hu, Bo Wang, Bing Qiang Zhao, Qian Guo, Zhonghua Li, Xinhui Zhang, Guang-Yao Liu, Ying Liu, Ying Chun Tang, Fan Luo, Ya Nan Du, Yaxin Chen, Liying Ma, Hong‐Min Liu (2017). Thiosemicarbazone-based selective proliferation inactivators inhibit gastric cancer cell growth, invasion, and migration. MedChemComm.DOI
  136. Zhonghua Li, Xue‐Qi Liu, Peng Geng, Jinlian Ma, Taoqian Zhao, Hao-Ming Wei, Bin Yu, Hong‐Min Liu (2017). Design, synthesis, and biological evaluation of new thiazolo[5,4-d]pyrimidine derivatives as potent antiproliferative agents. MedChemComm.DOI
  137. 张恩,王上,高洁,徐帅民,刘宏民(2016). 抗肿瘤活性化合物Jaspine B的合成进展. 《中国新药杂志》.
  138. 王超杰,周聪聪,曹钦坡,崔飞,宋攀攀,王雪琪,随敏,郑梦琳,陈新丽,张秋荣,刘宏民(2016). 酞嗪类化合物的合成及活性研究进展. 《中国药房》.
  139. 李永红,周方方,付路平,冯利菲,刘宏民(2016). RP-HPLC法同时测定酶法合成阿莫西林工艺中的原料、中间体和产物的含量. 《郑州大学学报(医学版)》.
  140. 王超杰,曹钦坡,杨慧,宋攀攀,薛登启,崔飞,顾一飞,张孝松,田亚楠,张秋荣,刘宏民(2016). 3,6-取代-1,2,4-三氮唑[3,4-a]酞嗪衍生物的合成和抗肿瘤活性评价. 《有机化学》.
  141. Yong-Cheng Ma, Yu Ke, X. Zi, Fei Zhao, Lin Yuan, Ying-Ming Zhu, Xia-Xia Fan, N. Zhao, Qiao-Yan Li, Yu-Hua Qin, Hongmin Liu (2016). Induction of the mitochondria-mediated apoptosis in human esophageal cancer cells by DS2, a newly synthetic diterpenoid analog, is regulated by Bax and caused by generation of reactive oxygen species. OncoTarget.DOI
  142. Fu‐Qiang Wang, Hui Yang, Bin He, Yong‐Kang Jia, Shi‐Yao Meng, Chao Zhang, Hong‐Min Liu, Feng‐Wu Liu (2016). ChemInform Abstract: A Novel Domino Approach for Synthesis of Indolyl Tetrahydropyrano[4,3‐c]pyrazole Derivatives as Anticancer Agents. ChemInform.DOI
  143. Xiaojing Shi, Lina Ding, Wenjuan Zhou, Yage Ji, Junwei Wang, Huimin Wang, Yong‐Cheng Ma, Guozhong Jiang, Kai Tang, Yu Ke, Wen Zhao, Hong‐Min Liu (2016). Pro-Apoptotic Effects of JDA-202, a Novel Natural Diterpenoid, on Esophageal Cancer Through Targeting Peroxiredoxin I. Antioxidants and Redox Signaling.DOI
  144. En Zhang, Wei-Wei Jiao, Shang Wang, Jinmei Xu, Xiaojing Shi, Yanchao Wang, Yana Wang, Hong‐Min Liu (2016). Design, synthesis, and preliminary evaluation of the biological activity of dithiocarbamate-3-epi-jaspine B hybrids. Medicinal Chemistry Research.DOI
  145. Fu-Qiang Wang, Hui Yang, Bin He, Yong‐Kang Jia, Shi‐Yao Meng, Chao Zhang, Hong‐Min Liu, Feng‐Wu Liu (2016). A novel domino approach for synthesis of indolyl tetrahydropyrano[4,3-c]pyrazole derivatives as anticancer agents. Tetrahedron.DOI
  146. Wenjuan Zhou, Liying Ma, Biao Hu, Lingyu Li, Bo Wang, Hong‐Min Liu, Wen He Zhao (2016). Abstract 3813: Potent compounds targeting the human MutT homolog 1 (hMTH1) activity and their cytotoxicity evaluation. Cancer Research.DOI
  147. Lihong Shan, Yang Li, Yanjie Chen, Minghui Yin, Jiajia Huang, Zhenzhong Zhang, Xiufang Shi, Hong‐Min Liu (2016). Microbial hydroxylation of 17β-estradiol by Penicillium brevicompactum. Biocatalysis and Biotransformation.DOI
  148. Lihong Shan, Kai Jiao, Minghui Yin, Jiajia Huang, Yanjie Chen, Shangshang Qin, Hong‐Min Liu (2016). Biotransformation of 5-en-3β-ol steroids byMucor circinelloides lusitanicus. Biocatalysis and Biotransformation.DOI
  149. Yanling Zhang, Yafei Li, Junwei Wang, Bin Yu, Yunkai Shi, Hong‐Min Liu (2016). Multicomponent assembly of novel antiproliferative steroidal dihydropyridinyl spirooxindoles. Steroids.DOI
  150. Juan Li, Yu Chen, Yanyan Diao, Yingqian Su, Qingli Wang, Zhicun Yao, Tianxiang Yi, Wenting Jin, Dan Yang Zhao, Caihong Wang, Mengru Liu, Hong‐Min Liu (2016). Identification of metabolites of the novel anti‐tumor drug candidate MDH‐7 in rat urine by liquid chromatography coupled with triple quadrupole linear ion trap mass spectrometry. Rapid Communications in Mass Spectrometry.DOI
  151. Dong‐Jun Fu, Sai‐Yang Zhang, Yingchao Liu, Xiao-Xin Yue, Junju Liu, Jian Song, Ruo-Han Zhao, Feng Li, Huihui Sun, Yanbing Zhang, Hong‐Min Liu (2016). Design, synthesis and antiproliferative activity studies of 1,2,3-triazole–chalcones. MedChemComm.DOI
  152. En Zhang, Hong‐Min Liu, Shang Wang, Jie Gao, Xiaojing Shi, Mingming Wang, Shuai-Min Xu (2016). Synthesis and Evaluation of the Antitumor Activities of Two Series of Jaspine B Analogues Bearing 2-Alkyloxymethyl Group. Heterocycles.DOI
  153. Dong‐Jun Fu, Sai‐Yang Zhang, Yingchao Liu, Xiao-Xin Yue, Junju Liu, Jian Song, Ruo-Han Zhao, Feng Li, Huihui Sun, Yanbing Zhang, Hong‐Min Liu (2016). Correction: Design, synthesis and antiproliferative activity studies of 1,2,3-triazole–chalcones. MedChemComm.DOI
  154. 马永成,苏楠,秦玉花,赵红卫,张伟,赵宁民,李巧艳,段虹飞,刘宏民(2015). 新天然化合物Jaridonin通过诱导氧化应激选择性杀伤肿瘤细胞. 《中国药理学通报》.
  155. 吴春丽,可钰,刘宏民(2015). 药学专业人才“产-学-研”结合教育模式的探索与实践. 《中国药房》.
  156. 付冬君,刘英超,李锋,张恩,刘宏民(2015). 氧头孢衍生物不对称合成的研究进展. 《有机化学》.
  157. 张京玉,王清龙,侯学会,刘宏民(2015). 具有嘌呤结构的细胞周期蛋白依赖性激酶抑制剂研究进展. 《有机化学》.
  158. 顾一飞,王超杰,曹钦坡,张孝松,陈鹏举,蒋腾飞,邵坤鹏,李博,可钰,张秋荣,刘宏民(2015). 新型2-取代苄基硫代嘧啶衍生物的合成及其细胞毒性. 《合成化学》.
  159. Bin Yu, De‐Quan Yu, Hong‐Min Liu (2015). ChemInform Abstract: Spirooxindoles: Promising Scaffolds for Anticancer Agents. ChemInform.DOI
  160. Yanling Zhang, Yafei Li, Yunkai Shi, Bin Yu, Guochen Zhang, Ping‐Ping Qi, Dong‐Jun Fu, Lihong Shan, Hong‐Min Liu (2015). Efficient three-component one-pot synthesis of steroidal polysubstituted anilines. Steroids.DOI
  161. Bin Yu, Zhiqiang Yu, Ping‐Ping Qi, De‐Quan Yu, Hong‐Min Liu (2015). ChemInform Abstract: Discovery of Orally Active Anticancer Candidate CFI‐400945 Derived from Biologically Promising Spirooxindoles: Success and Challenges. ChemInform.DOI
  162. 王幸,郭燕子,曹川,王少敏,刘宏民(2014). HPLC/MS法测定利福霉素钠原料药中的相关物质. 《中国化学会首届全国质谱分析学术研讨会会议论文集》.
  163. 侯学会,张京玉,刘宏民(2014). 多靶点受体酪氨酸激酶抑制剂ABT-869的有效合成方法. 《有机化学》.
  164. 侯学会,马志伟,王建玲,刘宏民(2014). 双功能手性硫脲催化的不对称Michael加成反应研究进展. 《有机化学》.
  165. Bei-Xi Jia, Qian-Qian Huangfu, Feng‐Xiao Ren, Lu Jia, Yanbing Zhang, Hong‐Min Liu, Jie Yang, Wang Qiang (2014). Identification and quantification of flavonoids and chromes inBaeckea frutescensby using HPLC coupled with diode-array detection and quadruple time-of-flight mass spectrometry. Natural Product Research.DOI
  166. Qiu‐Rong Zhang, Deng‐Qi Xue, Peng He, Kun‐Peng Shao, Peng‐Ju Chen, Yifei Gu, Jingli Ren, Lihong Shan, Hong‐Min Liu (2014). ChemInform Abstract: Synthesis and Antimicrobial Activities of Novel 1,2,4‐Triazolo[3,4‐a]phthalazine Derivatives. ChemInform.DOI
  167. 王盟盟,段迎超,叶先炜,任景丽,余斌,张恩,刘宏民(2013). 新型1,4-双哌嗪二硫代甲酸[1-取代(1,2,3-三唑)-4]-甲酯类化合物的设计、合成和抗肿瘤活性研究. 《有机化学》.
  168. 刘改枝,韩德恩,王鹏,刘宏民(2013). 罗非昔布及其衍生物合成研究进展. 《有机化学》.
  169. 刘改枝,吴亚,徐海伟,刘宏民(2013). 绿色合成抗癫痫药氯西加酮及其类似物. 《有机化学》.
  170. 张恩,王亚娜,赵兵,郑甲信,刘宏民(2013). 提高药物化学实验课教学质量的新思路. 《海峡药学》.
  171. 张恩,李聪,张保寅,吕爱桥,方园,冯思琦,刘宏民(2013). 利斯的明消旋体的高效实用合成. 《有机化学》.
  172. 徐海伟,赵玲洁,车雪萍,郑晨星,王飞,刘龙飞,刘宏民(2013). 基于天然产物的多取代2(H)呋喃酮类衍生物的设计、合成及肿瘤细胞增殖抑制活性研究. 《2013年全国药物化学学术会议暨第四届中英药物化学学术会议会议指南》.
  173. Xu Henan, Lan Zhang, Hong‐Min Liu, Sijie Liu, Huangquan Lin, Yan Wang, David Chi‐Cheong Wan, Chun Hu (2013). Synthesis, characterization and biological activity of 3-aryl-6-(4-fluorobenzyl)-7H-thiazolo[3,2-b]-1,2,4-triazin-7-one derivatives as novel acetylcholinesterase inhibitors. Rare & Special e-Zone (The Hong Kong University of Science and Technology).
  174. Qiurong Zhang, Guangqiang Zhou, Peng He, Xuebin Chen, Hong‐Min Liu (2013). 1,2:1′,2′-Di-O-isopropylidenedifuranose-C12 higher carbon sugar. Acta Crystallographica Section E Structure Reports Online.DOI
  175. Qiurong Zhang, Peng He, Guangqiang Zhou, Kang Yu, Hong‐Min Liu (2013). 4-Cyclopropyl-1-(6′-deoxy-1′,2′-O-isopropylidene-α- D -glucofuranosyl)-1H-1,2,3-triazole. Acta Crystallographica Section E Structure Reports Online.DOI
  176. Bin Yu, En Zhang, Yuan Fang, Xiaonan Sun, Jingli Ren, De‐Quan Yu, Hong‐Min Liu (2013). ChemInform Abstract: The New Convenient Synthesis of Novel γ‐Alkylidenebutenolides from 6‐Aminopenicillanic Acid. ChemInform.DOI
  177. 单丽红,赵兵,张秋荣,刘宏民(2012). 以“教学团队”建设为契机 深化药物化学教学改革. 《中国中医药现代远程教育》.
  178. 李娟,涂祖月,尹俊源,陈家威,刘宏民(2012). LC-MS/MS法测定大鼠尿液中GP2及其排泄动力学研究. 《第十届全国药物和化学异物代谢学术会议暨第三届国际ISSX/CSSX联合学术会议论文集》.
  179. 张宝乐,秦伟,段迎超,余斌,张恩,刘宏民(2012). 手性吲哚啉衍生物合成方法的研究进展. 《有机化学》.
  180. 赵明礼,赵玉涛,张召,高洁,屈文,徐锦梅,刘宏民(2012). 抗肿瘤药物卡培他滨的合成新方法. 《高等学校化学学报》.
  181. 张秋荣,蒋腾飞,王惠,邵坤鹏,刘宏民(2012). 双嘧达莫的合成工艺改进. 《合成化学》.
  182. Yonghong Li, Li‐Hua Huang, Hong‐Min Liu (2012). ChemInform Abstract: Chemoenzymatic Route to (S)‐Betaxolol (IV). ChemInform.DOI
  183. Li‐Hua Huang, Yanguang Wang, Gong Xu, Xiang‐Hua Zhang, Yong‐Fei Zheng, Hui‐Li He, Wen‐Zheng Fu, Hong‐Min Liu (2012). ChemInform Abstract: Novel 4‐Azasteroidal N‐Glycoside Analogues Bearing Sugar‐Like D Ring: Synthesis and Anticancer Activities. ChemInform.DOI
  184. 陈学彬,王惠,于康,贺鹏,张秋荣,刘宏民(2011). 新型双呋喃环核苷类化合物的合成. 《2011年全国药物化学学术会议——药物的源头创新》.
  185. 陈婷,于康,周广强,王惠,张秋荣,刘宏民(2011). 羟基保泰松类化合物的合成及活性研究. 《2011年全国药物化学学术会议——药物的源头创新论文摘要集》.
  186. 王姣,赖耀文,谷金灿,田丹,乔星,刘宏民(2011). 利斯的明化学生物合成路线的初步研究. 《2011年全国药物化学学术会议——药物的源头创新论文摘要集》.
  187. 范子祺,郭晓东,车雪萍,王飞,郑晨星,刘宏民,徐海伟(2011). Pulvinones类化合物全合成方法研究. 《2011年全国药物化学学术会议——药物的源头创新论文摘要集》.
  188. 赵兵,李颖慧,刘宏民(2011). NMR在克伦特罗(瘦肉精)手性拆分中的新应用. 《2011年全国药物化学学术会议——药物的源头创新》.
  189. 毕跃峰,关若飞,赵静,陈园园,阿有梅,刘宏民(2011). 基于拼合原理的丹参酮ⅡA与苯甲酸类衍生物的合成研究. 《2011年全国药物化学学术会议——药物的源头创新》.
  190. 车雪萍,王飞,郭晓东,郑晨星,刘宏民,徐海伟(2011). 多取代呋喃类化合物的合成及生物活性研究. 《2011年全国药物化学学术会议——药物的源头创新论文摘要集》.
  191. 周甜,李娟,陈明,涂祖月,尹俊源,岳国霞,刘宏民(2011). LC-MS/MS法测定大鼠血浆中GP2浓度. 《2011年全国药物化学学术会议——药物的源头创新》.
  192. 王航,李伟义,刘宏民,徐海伟(2011). 15-芳亚基异穿心莲内酯衍生物及其抗菌活性. 《2011年全国药物化学学术会议——药物的源头创新论文摘要集》.
  193. 刘文省,王飞,郭晓东,车雪萍,郑晨星,刘宏民,徐海伟(2011). 3-芳基-4-烷氧基-5-烷基取代丁烯内酯类化合物的合成及抗菌活性. 《2011年全国药物化学学术会议——药物的源头创新论文摘要集》.
  194. 黄新苹,可钰,冯凯,李惠举,刘宏民(2011). 女贞子石油醚提取物的化学成分研究. 《中国药学杂志》.
  195. 冯贝贝,周广强,于康,王惠,张秋荣,刘宏民(2011). 2-吲哚酮衍生物的合成及抗肿瘤活性评价. 《2011年全国药物化学学术会议——药物的源头创新》.
  196. 周广强,王惠,陈婷,于康,张秋荣,刘宏民(2011). 5C-分支糖衍生物的合成研究. 《2011年全国药物化学学术会议——药物的源头创新》.
  197. 朱楠,于康,王慧,薛登启,张秋荣,刘宏民(2011). 苯胺酞嗪类化合物的合成及抗肿瘤活性研究. 《2011年全国药物化学学术会议——药物的源头创新》.
  198. 王丽,马慧艳,李爱星,李晓晨,李琳,张保寅,刘宏民(2011). 4-萜品醇破坏性研究. 《2011年全国药物化学学术会议——药物的源头创新》.
  199. 郭晓,王晓娟,郑晨星,郭晓东,王飞,徐海伟,刘宏民(2011). 新型含α-亚甲基-γ-丁内酯的酯类化合物的设计、合成. 《2011年全国药物化学学术会议——药物的源头创新》.
  200. 郭晓,王晓娟,郑晨星,王飞,郭晓东,徐海伟,刘宏民(2011). 含α-亚甲基-γ-丁内酯的氨基二硫代甲酸酯类化合物的设计、合成. 《2011年全国药物化学学术会议——药物的源头创新》.
  201. 李鹏云,陈雪平,孙伟,赵明礼,张召,张秋荣,刘宏民(2011). 亚氨基氮杂糖化合物及其核苷衍生物的合成. 《2011年全国药物化学学术会议——药物的源头创新》.
  202. 王培,赵鹏,王卫娜,任清华,刘宏民(2011). 氯吡格雷中间体合成及其质量控制研究. 《2011年全国药物化学学术会议——药物的源头创新》.
  203. 吴先兵,马立英,张恩,刘宏民(2011). 头孢他啶中间体7-APCA的合成工艺优化. 《2011年全国药物化学学术会议——药物的源头创新》.
  204. 郑晨星,王晓娟,郭晓,郭晓东,王飞,徐海伟,刘宏民(2011). 新型含丁烯内酯结构的氨基二硫代类化合物的设计合成. 《2011年全国药物化学学术会议——药物的源头创新》.
  205. 王晓娟,郭琳琳,陈广威,徐永刚,郭晓,徐海伟,刘宏民(2011). (R)-(+)-和(S)-(-)磷酸苯并哌林对映体的合成新方法. 《有机化学》.
  206. 严琳,刘丰五,刘宏民(2011). 新型呋喃基Schiff碱衍生物的合成、结构和生物活性. 《有机化学》.
  207. 刘宏民(2011). γ-丁烯内酯类化合物的设计合成及生物活性评价. 《2011年全国药物化学学术会议——药物的源头创新》.
  208. 张保寅,张恩,王文华,郭跃燕,刘宏民(2011). 治疗早泄药物达泊西汀的有机催化不对称合成. 《2011年全国药物化学学术会议——药物的源头创新》.
  209. 陈明,李娟,宋树美,周甜,尹俊源,岳国霞,刘宏民(2011). GP2在大鼠体内的组织分布研究. 《2011年全国药物化学学术会议——药物的源头创新》.
  210. 尹俊源,李娟,涂祖月,陈明,周甜,岳国霞,刘宏民(2011). GP2在大鼠体内的排泄研究. 《2011年全国药物化学学术会议——药物的源头创新》.
  211. 张秋荣,季聪慧,杨志华,蒋腾飞,石晓静,贺鹏,刘宏民(2011). 头孢替唑钠的合成工艺研究. 《中国药物化学杂志》.
  212. Haiwei Xu, Pingjuan Jiang, Weiyi Li, Junfeng Wang, Hong‐Min Liu (2011). Synthesis and Bioactivities of Andrographolide Derivatives: New (−)‐Limonidilactone Analogues. Chinese Journal of Chemistry.DOI
  213. Xiaojuan Wang, Haiwei Xu, Linlin Guo, En Zhang, Guang‐Wei Chen, Xiao Ping Guo, Hong‐Min Liu (2011). ChemInform Abstract: Synthesis of Various Substituted Spiro‐ and Bicyclethiazolidine‐2‐thiones by a Multicomponent Reaction and Biological Evaluation in vitro. ChemInform.DOI
  214. Jingyu Zhang, Xuehui Hou, Hong‐Min Liu (2011). Synthesis, Crystal Structure and Hydrolysis of a Novel Anhydrogalactosucrose: 2′‐Methoxyl‐O‐1′,4′:3′,6′‐dianhydro‐β‐D‐fructofuranosyl 3,6‐anhydro‐4‐chloro‐4‐deoxy‐α‐D‐galactopyranoside. Chinese Journal of Chemistry.DOI
  215. Li‐Hua Huang, Yanguang Wang, Gong Xu, Xiang-Hua Zhang, Yong‐Fei Zheng, Hui-Li He, Wenzheng Fu, Hong‐Min Liu (2011). Novel 4-azasteroidal N-glycoside analogues bearing sugar-like D ring: Synthesis and anticancer activities. Bioorganic & Medicinal Chemistry Letters.DOI
  216. Qiurong Zhang, Xuebin Chen, Nan Zhu, Tengfei Jiang, Hong‐Min Liu (2011). 3,5-Di-O-benzoyl-1,2-O-isopropylidene-α- D -ribo-hexos-3-ulo-1,4:3,6-difuranose. Acta Crystallographica Section E Structure Reports Online.DOI
  217. Qiurong Zhang, Pan Li, Xuebin Chen, Xiandong Wang, Hong‐Min Liu (2011). 3,6-Didehydro-5-hydroxy-1,2-O-isopropylidene-5-C-nitromethyl-α- D -glucofuranose. Acta Crystallographica Section E Structure Reports Online.DOI
  218. Qiurong Zhang, Chunli Wu, Pengyun Li, Weiyan Cheng, Hong‐Min Liu (2011). N-Benzyl-6-deoxy-3,6-iminomethylene-1,2,3,5-O-tetraacetyl-α- D -1(S)-epiallofuranose. Acta Crystallographica Section E Structure Reports Online.DOI
  219. Hong Shu Liu, Fuyi Zhang, Jinpeng Li, Xuebin Yan, Hong‐Min Liu, Yufen Zhao (2011). Novel Methyl 4,6-O-benzylidene-3-ketoglucopyranosid-fused γ-lactam: Synthesis and Crystal Structure. Journal of Chemical Crystallography.DOI
  220. Hai-Yan Zhang, Tian-Zeng Zhao, Yue Zhou Wei, Hong‐Min Liu (2011). Two new sesquiterpene polyol esters from the root barks ofCelastrus angulatus. Journal of Asian Natural Products Research.DOI
  221. 张雁冰,张全海,靳银杰,刘宏民(2010). 皇冠化学成分研究. 《中国化学会第八届天然有机化学学术研讨会》.
  222. 徐永刚,朱松林,弓颖,冯凯,可钰,郑甲信,刘宏民(2010). 冬凌草中对映贝壳杉烯型活性二萜的16,17位结构修饰. 《中国化学会第八届天然有机化学学术研讨会》.
  223. 李攀,吴春丽,潘小涛,吴继洲,刘宏民(2010). 生物碱中菲啶酮环骨架的构建. 《中国化学会第八届天然有机化学学术研讨会》.
  224. 李雯,肖博,周游,刘宏民(2010). 丙米嗪类似物的合成及其镇痛活性研究. 《有机化学》.
  225. 毕跃峰,潘成学,王普菊,裴姗姗,张雁冰,刘宏民(2009). 野菊花化学成分的研究. 《中国药学杂志》.
  226. 李华雨,刘宏民,卜闪闪,李娟,韩冬,吴广银,王少敏,张明智(2009). HPLC/ESI-Q-TOFMS鉴定淋巴癌患者尿液中的修饰核苷. 《高等学校化学学报》.
  227. Lihong Shan, Hong‐Min Liu, Ke-xue Huang, Gui‐Fu Dai, Chen Cao, Rui-Jing Dong (2009). Synthesis of 3β, 7α, 11α-trihydroxy-pregn-21-benzylidene-5-en-20-one derivatives and their cytotoxic activities. Bioorganic & Medicinal Chemistry Letters.DOI
  228. 王少敏,李娟,李华雨,刘宏民,李雯(2008). 二丁基氧化锡脱脂肪族糖苷乙酰保护基的研究. 《有机化学》.
  229. 李华雨,韩冬,李娟,王少敏,刘宏民(2008). HPLC-ESI-TOFMS检测尿液中的雌二醇. 《化学研究》.DOI
  230. 李娟,徐海伟,王少敏,李华雨,韩冬,刘宏民(2008). β-环糊精与青蒿素类药物非共价复合物的电喷雾质谱研究. 《分析化学》.
  231. 张红雨,刘宏民,陈晓岚,屈凌波,赵玉芬(2008). 由羰基糖合成氮杂糖. 《化学通报(中英文)》.
  232. 单丽红,曹晨,张洪杰,刘宏民(2008). 3β-乙酰氧基-17a-氮杂-D-homo-5(6)-雄甾烯-17-酮的化学合成与生物转化. 《郑州大学学报(医学版)》.
  233. 刘改芝,徐海伟,孙凯,王君,刘宏民(2008). 穿心莲内酯衍生物的合成研究进展. 《有机化学》.
  234. Heping Li, Yu Peng, Hongjie Zhang, Hong‐Min Liu (2008). ChemInform Abstract: Synthesis of 5‐Androstene‐3β,7α,17β‐triol and 5‐Androstene‐3β,7β,17β‐triol. ChemInform.DOI
  235. Yanbing Zhang, Piyong Zhang, Gui‐Fu Dai, Hong‐Min Liu (2008). ChemInform Abstract: Study on the Synthesis and Bioactivity of Novel Mahkoside A Derivatives. ChemInform.DOI
  236. Hong‐Min Liu (2008). Synthesis of 7α-OH-Dehydroepiandrosterone and Evaluation of Its Bioactivity. Zhōnghuá yàoxué zázhì.
  237. 黄利华,徐海伟,刘改芝,戴桂馥,刘宏民(2007). (8R,13R)-8,12,13,17-四氢穿心莲内酯的合成、晶体结构和葡萄糖苷酶抑制活性. 《高等学校化学学报》.
  238. 孙贺平,姬小明,戴桂馥,张博,刘宏民(2007). D-呋喃核糖长链酰基衍生物的合成及生物活性研究. 《有机化学》.
  239. 李娟,戴桂馥,王少敏,刘宏民(2007). ESI-MS测定牛血清白蛋白分子量过程中的pH影响. 《化学研究》.
  240. 徐顺,赵晓洋,李瑞玲,刘宏民(2007). (E)-N-(4-氨基正丁基)-3-(3-羟基-4-甲氧基-苯基)丙烯酰胺顺反构象异构化的理论研究. 《计算机与应用化学》.
  241. 毕跃峰,田野,裴姗姗,张聪,刘宏民(2007). 金银花化学成分分析. 《郑州大学学报(理学版)》.
  242. 刘宏民,姬小明,孙贺平,付玉红,张博(2007). 氨基糖衍生物的NMR碳氢化学位移完全解析. 《郑州大学学报(理学版)》.
  243. Haiwei Xu, Gai‐Zhi Liu, Gui‐Fu Dai, Chunli Wu, Hong‐Min Liu (2007). Modification of 15-akylidene andrographolide derivatives as alpha-glucosidase inhibitor. PubMed.
  244. 刘宏民,刘宏民 姚双吉 杨利坡 庞志峰 李双来 刘武斌 闫胜友 褚建东(2006). 高速线材吐丝机吐丝管空间曲线研究和改进. 《中国工程科学》, Vol. 8, No. 11.下载原文
  245. 王少敏,邹大鹏,张建业,李华雨,刘宏民(2006). 高效液相色谱/串联质谱法快速鉴定Z/E盐酸头孢吡肟异构体. 《分析化学》.
  246. 张雁冰,朱献民,王克让,刘宏民(2006). 马桑籽中活性成分马桑内酯类化合物的研究. 《第七届全国磷化学化工暨第四届海峡化学生物学、生物技术与医药发展讨论会》.
  247. 陈改敏,张建业,张向沛,刘宏民(2006). 马鞭草黄酮类化学成分的研究. 《中药材》.DOI
  248. 张雁冰,张丕永,徐向军,刘宏民(2006). 皇冠苷A衍生物的合成. 《第七届全国磷化学化工暨第四届海峡化学生物学、生物技术与医药发展讨论会》.
  249. 徐顺,王林江,李瑞玲,刘宏民(2006). 白英全草中挥发油化学成分分析. 《时珍国医国药》.
  250. 李瑞军,李德耀,张现峰,任冬春,刘宏民(2006). 大孔吸附树脂法去除淫羊藿多糖中蛋白的研究. 《高等学校化学学报》.
  251. 张雁冰,戴桂馥,侯立芬,寇娴,刘宏民(2006). 马桑中黄酮的免疫调节作用研究. 《第七届全国磷化学化工暨第四届海峡化学生物学、生物技术与医药发展讨论会》.
  252. 徐顺,凌勋利,刘宏民,王翀(2006). 香草酸糖酯的合成研究. 《化学研究与应用》.
  253. 闫学斌,雷萌,可钰,屈红丽,尹鹏,刘宏民(2006). 冬凌草的化学成分研究. 《化学研究》.
  254. Haiwei Xu, Jianye Zhang, Hong‐Min Liu, Jun‐Feng Wang (2006). Synthesis of Andrographolide Cyclophosphate Derivatives and Their Antitumor Activities. ChemInform.DOI
  255. Gui‐Fu Dai, Haiwei Xu, Junfeng Wang, Feng‐Wu Liu, Hong‐Min Liu (2006). Studies on the Novel α‐Glucosidase Inhibitory Activity and Structure—Activity Relationships for Andrographolide Analogues. ChemInform.DOI
  256. 张建业,刘玉坤,可钰,邹大鹏,刘宏民(2005). HPLC分析法在克林霉素磷酸酯合成工艺中的应用. 《化学研究》.
  257. 姬小明,严琳,付玉红,于梅艳,刘宏民(2005). 氨基糖合成过程中的酰基转位. 《中国化学会第四届有机化学学术会议论文集(上册)》.
  258. 张雁冰,戴桂馥,侯立芬,王克让,刘宏民(2005). 马桑叶中黄酮类化合物提取和生物活性研究. 《中国化学会第四届有机化学学术会议论文集(上册)》.
  259. 张京玉,严琳,刘丰五,王俊峰,刘宏民(2005). 新型手性光学纯β-氨基醇的合成与研究. 《中国化学会第四届有机化学学术会议论文集(上册)》.
  260. 吕敏,孙凯,李欣,胡满义,邹大鹏,刘宏民(2005). C 10 高碳糖酰基衍生物的合成研究. 《中国化学会第四届有机化学学术会议论文集(下册)》.
  261. 张雁冰,王克让,张运晓,薛华珍,刘宏民(2005). 马桑叶中总三萜酸的含量测定. 《中国化学会第四届有机化学学术会议论文集》.
  262. 张建业,陈改敏,可钰,戴桂馥,王艳佳,刘宏民(2005). 二丁基氧化锡催化九乙酰基毛蕊花苷的脱乙酰化反应及产物的生物活性研究. 《中国化学会第四届有机化学学术会议论文集》.
  263. 张建业,洪广峰,可钰,张向沛,谭浩瀚,刘宏民(2005). 戟叶马鞭草苷衍生物合成中的甲氧基-迁移现象. 《中国化学会第四届有机化学学术会议论文集》.
  264. 李德耀,李瑞军,洪广峰,张红雨,刘宏民(2005). 过氧化酮(Dioxiranes)的研究和应用新进展. 《有机化学》.
  265. 阎学斌,雷萌,张建业,刘宏民(2005). 冬凌草甲素葡萄糖苷的合成. 《有机化学》.
  266. 徐顺,张勇,赵晓洋,刘宏民(2005). 常用化学软件多媒体教学软件的开发研究. 《计算机与应用化学》.
  267. 张雁冰,李玲,刘宏民,王克让,徐向军,朱献民(2005). 马桑化学成分研究. 《郑州大学学报(理学版)》.
  268. Hong‐Min Liu, Feng‐Wu Liu, Dapeng Zou, Gui‐Fu Dai (2005). Asymmetric Synthesis of Novel Tetrahydroquinoline Derivatives with a Sugar Building Block and Their Bioactivities. ChemInform.DOI
  269. WU Chun-li, Qiurong Zhang, Shan Li-hong, Yankai Liu, Hong‐Min Liu (2005). Improved synthesis of danofloxacin. Zhongguo yaowu huaxue zazhi.
  270. 李石,徐海伟,曹鸿志,刘宏民(2004). 以5-位氧化葡萄糖为原料的新型氨基糖的合成. 《第三届全国有机化学学术会议论文集(上册)》.
  271. 葛文中,刘宏民,莫娟,任丽鸽(2004). 孕甾烯酮的C-15羟基衍生物的生物合成. 《第三届全国有机化学学术会议》.
  272. 邹大鹏,莫娟,张惠君,刘宏民(2004). 新型烯醇醚高碳糖的自动氧化及晶体结构. 《第三届全国有机化学学术会议》.
  273. 陶京朝,弓建红,陈新华,刘星,刘宏民(2004). 新型氮杂大环化合物的合成及其超分子识别性能. 《第三届全国有机化学学术会议》.
  274. 徐顺,王宠,王林江,刘宏民(2003). 分子轨道对称性和反应机理的计算机模拟. 《计算机与应用化学》.
  275. 李雯,刘宏民,尤启冬(2003). 二丁基氧化锡在糖苷类化合物脱乙酰保护基中的应用. 《化学学报》.
  276. 刘宏民,可钰,刘振中(2003). 四氯蔗糖及其衍生物的NMR碳氢化学位移完全解析及结构研究. 《波谱学杂志》.
  277. 刘宏民,张福义,徐汶,李石(2003). 以氧化糖为原料的氨基糖衍生物的合成. 《化学学报》.
  278. Hong‐Min Liu, Fuyi Zhang, Dapeng Zou (2003). Stereoselective Synthesis of 2,2‐Bis(C‐Branched‐Chain)glucopyranosid‐3‐ulose via an Autoxidation—Michael Addition Reaction. ChemInform.DOI
  279. 李雯,刘宏民(2002). 对位取代苯酚氧甙类化合物的相转移催化合成与结构表征. 《有机化学》.
  280. Fuyi Zhang, Chenxia Du, Hong‐Min Liu, Yu Zhu (2002). ChemInform Abstract: A Novel Glycoside Lactone Derivative with a 2‐C‐Unsaturated Diester Substituent. ChemInform.DOI

预印本

  1. Yi‐Chao Zheng, Jingru Pang, Yu Zhang, Hao Zhu, Dandan Shen, Bo Wang, Yan Li, Guo‐Liang Lu, Ning Wang, Zheng-Hong Yang, Xin Dai, Hong‐Min Liu (2026). Targeting LSD1 inhibits gastric cancer by reprogramming macrophages and restoring T-cell response. Research Square.DOI
  2. Liying Ma, Xinhui Zhang, Haiqian Nie, Junru Zhao, Mengkai Feng, Xiaoqian Yu, Yulin Liu, Huiqin Kang, Yuanfan Liu, Shiyu Li, Hong‐Min Liu, Ya Gao (2025). Design, Synthesis and Biological Evaluation of Novel Indole-Capped Histone Deacetylase 6 Inhibitors as Anti-Gastric Cancer Agents. SSRN Electronic Journal.DOI
  3. Liying Ma, Xinhui Zhang, Haiqian Nie, Junru Zhao, Mengkai Feng, Yulin Liu, Huiqin Kang, Yuanfan Liu, Shiyu Li, Hong‐Min Liu, Ya Gao (2025). Design, Synthesis and Biological Evaluation of Novel Histone Deacetylase 6 Inhibitors Containing Indole-Based Cap Groups. SSRN Electronic Journal.DOI
  4. Linyue Bai, Liang Shen, Qianqian Zhang, Zhuang Hu, Yanjun Tang, Mengjie Fu, Hong‐Min Liu, Xing‐Jie Dai, Siqi Feng (2024). Accelerating Small Molecule Ferroptosis Regulator Development with Advances in Biological Functions.DOI
  5. yanzhi wang, Linchao Wang, H.M. Chang, qing shen, sai zhang, Shanshan Sun, Ying Liu, Jiaxin Zheng, Hong‐Min Liu (2023). Enhancing anti-tumor therapy with agmatine-cholesterol conjugate liposomes: in vitro and in vivo evidence. Research Square.DOI
  6. Xiaojie Si, Fuqiang Yu, Hao Wang, Lingling Chi, Honglin Dai, Chao Gao, Yingnan Zhu, Hong‐Min Liu, Qiurong Zhang (2023). Design, synthesis and antitumor activity evaluation in vitro of 4,6,7-trisubstituted quinazoline derivatives containing acrylamide moiety. Research Square.DOI

此主页由公开资料整理,尚未经学者本人认领。